Secondary
Acer Therapeutics, Inc.
They are a a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need.
Symbol
ACER
Last Closing Price
$14.15
Effective Date
December 12, 2017
Underwriters
William Blair
To view the prospectus for Acer Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277